ABVC (ABVC BioPharma, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
ABVC BioPharma, Inc. Common Stock (ABVC) is a publicly traded Healthcare sector company. As of May 21, 2026, ABVC trades at $1.10 with a market cap of $27.43M and a P/E ratio of -2.67. ABVC moved +1.82% today. Year to date, ABVC is -53.19%; over the trailing twelve months it is -19.71%. Its 52-week range spans $0.40 to $5.48. Rallies surfaces ABVC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns ABVC stock?
Hedge funds tracked by Rallies that own ABVC include Citadel Advisors and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for ABVC BioPharma, Inc. Common Stock.
ABVC Key Metrics
Key financial metrics for ABVC
Metric
Value
Price
$1.10
Market Cap
$27.43M
P/E Ratio
-2.67
EPS
$-0.39
Dividend Yield
0.29%
52-Week High
$5.48
52-Week Low
$0.40
Volume
0
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-8.38M
Gross Margin
0.00%
Top Hedge Funds Holding ABVC
Citadel Advisors holds 40.74K shares of ABVC, changed +61.60% as of Dec 31, 2024.
Two Sigma holds 12.59K shares of ABVC, changed +1.58% as of Dec 31, 2024.
ABVC analyst coverage data. Average price target: $0.00.
Common questions about ABVC
Who owns ABVC stock?
Hedge funds tracked by Rallies that own ABVC include Citadel Advisors and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for ABVC BioPharma, Inc. Common Stock.
Does Rallies show 13F holders for ABVC?
Yes. Rallies tracks hedge fund and 13F ownership data for ABVC, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ABVC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ABVC. It does not provide personalized investment advice.
